India Active Pharmaceutical Ingredients Market, by Product Type (Low Potent APIs and High Potent APIs), by Molecule Type (Acetaminophen, Naproxen, Dextromethorphan Hydrobromide, Gabapentin, Ciprofloxacin, Ofloxacin, Mirtazapine, Sotalol, Levetiracetam, Sa

India Active Pharmaceutical Ingredients Market, by Product Type (Low Potent APIs and High Potent APIs), by Molecule Type (Acetaminophen, Naproxen, Dextromethorphan Hydrobromide, Gabapentin, Ciprofloxacin, Ofloxacin, Mirtazapine, Sotalol, Levetiracetam, Salmeterol, Salbutamol, Fexuprazan, Diclofenac, Azithromycin, Afatinib dimaleate, Apixaban, Bendamustine, Bosentan Monohydrate, Atorvastin Calcium, Atorvastin Calcium, Ibuprofen, Praziquantel, Oseltamivir - Process A, Lanthanum Carbonate Octa, Sevelamer Carbonate, Succinyl Choline Chloride, and Others), by Formulation (Oral, Topical, Injectables, and Drops), by Application (Diabetes, Oncology, Cardiovascular, CNS, Analgesics, Dermatology, Respiratory, Opthalmic, and Others), and by Region (North India, South India, East India, West India, and Central India) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The active pharmaceutical ingredient (API) in a medication is the component that causes the desired effects. Active pharmaceutical ingredients are mostly manufactured at big manufacturing factories and its manufacturing process involves a series of operations such as multi-step chemical synthesis, fermentation, purification, crystallization, drying, milling, packing, labeling, and testing. They may also be examined by foreign government agencies, and third-party corporations may conduct audits at API facilities. APIs must meet the quality and safety requirements imposed by the producing country. Even if the production is outsourced, API businesses must adhere to the rigorous requirements of the relevant health authorities. Most of the active pharmaceutical ingredient companies are headquartered in India. However, because the bulk API production takes place in mostly Asian countries such as China, they are the source of the majority of APIs produced worldwide.
Market Dynamics
The active pharmaceutical ingredients manufacturers are starting production units in India to remain competitive and gain benefit over other competitors, which is projected to fuel the market growth during the forecast period. For instance, in February 2017, Nacto pharma, an Indian multinational pharmaceutical company, planned to invest around US$ 1 Billion and expand its active pharmaceutical ingredient (API) and intermediates manufacturing facility in Tamil Nadu.
Key features of the study:
This report provides an in-depth analysis of the India active pharmaceutical ingredient market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the India active pharmaceutical ingredients market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Salora, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Lupin Limited, Sun Pharmaceutical Industries Limited, Divi’s Laboratories Ltd., Aarti Drugs Ltd., Hikal Ltd., Neuland Labs, Century Pharmaceuticals Ltd., Proventus Life Sciences Pvt Ltd, Chiral Drugs Pvt Ltd, USV Private Limited, and ASolution Pharmaceuticals Pvt. Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The India active pharmaceutical ingredient market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the India active pharmaceutical ingredient market
Detailed Segmentation:
India Active Pharmaceutical Ingredient Market, By Product Type:
Low Potent APIs
High Potent APIs
India Active Pharmaceutical Ingredient Market, By Molecular Type:
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
India Active Pharmaceutical Ingredient Market, By Formulation:
Oral
Topical
Injectables
Drops
India Active Pharmaceutical Ingredient Market, By Application:
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
India Active Pharmaceutical Ingredient Market, By Region:
North India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Delhi
Uttar Pradesh
Rajasthan
Punjab
Others
South India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Tamil Nadu
Kerala
Andhra Pradesh
Telangana
Others
East India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Bihar
Jharkhand
West Bengal
Others (North East India)
West India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Maharashtra
Goa
Gujarat
Central India
By Product Type
Low Potent APIs
High Potent APIs
By Molecular Type
Acetaminophen
Naproxen
Dextromethorphan Hydrobromide
Gabapentin
Ciprofloxacin
Ofloxacin
Mirtazapine
Sotalol
Levetiracetam
Salmeterol
Salbutamol
Fexuprazan
Diclofenac
Azithromycin
Afatinib dimaleate
Apixaban
Bendamustine
Bosentan Monohydrate
Atorvastin Calcium
Atorvastin Calcium
Ibuprofen
Praziquantel
Oseltamivir - Process A
Lanthanum Carbonate Octa
Sevelamer Carbonate
Succinyl Choline Chloride
Others
By Formulation
Oral
Topical
Injectables
Drops
By Application
Diabetes
Oncology
Cardiovascular
CNS
Analgesics
Dermatology
Respiratory
Ophthalmic
Others
By States
Madhya Pradesh
Chhattisgarh
Company Profiles
Teva Pharmaceutical Industries Ltd *
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Salora
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
Lupin Limited
Sun Pharmaceutical Industries Limited
Divi’s Laboratories Ltd.
Aarti Drugs Ltd.
Hikal Ltd.
Neuland Labs
Century Pharmaceuticals Ltd.
Proventus Life Sciences Pvt Ltd
Chiral Drugs Pvt Ltd
USV Private Limited
ASolution Pharmaceuticals Pvt. Ltd.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Product Type
Market Snapshot, By Molecule Type
Market Snapshot, By Formulation
Market Snapshot, By Application
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Opportunity
Impact Analysis
Pipeline Analysis
Regulatory Scenario
Market Trends
Key Developments
Epidemiology
PEST Analysis
Brand Analysis
4. India Active Pharmaceutical Ingredients Market– Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply and Demand Analysis
Key Developments
5. India Active Pharmaceutical Ingredients Market, By Product Type, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
High Potent APIs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Low Potent APIs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. India Active Pharmaceutical Ingredients Market, By Molecule Type, By , 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Acetaminophen
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Naproxen
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Dextromethorphan Hydrobromide
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Ciprofloxacin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Ofloxacin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Mirtazapine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Sotalol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Levetiracetam
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Salmeterol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Salbutamol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Fexuprazan
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Diclofenac
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Pantoprazole
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Azithromycin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Afatinib dimaleate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Apixaban
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Bendamustine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Bosentan Monohydrate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Atorvastin Calcium
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Ibuprofen
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Gabapentin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Praziquantel
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Oseltamivir - Process A
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Lanthanum Carbonate OCTA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Sevelamer Carbonate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Succinyl Choline Chloride
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. India Active Pharmaceutical Ingredients Market, By Formulation, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Injectables
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Drops
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
8. India Active Pharmaceutical Ingredients Market, By Application, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Diabetes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Cardiovascular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
CNS
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Analgesics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Dermatology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Respiratory
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Ophthalmic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
9. India Active Pharmaceutical Ingredients Market, By Region, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North India
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
South India
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
East India
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
West India
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Central India
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
10. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Teva Pharmaceutical Industries Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Solara
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Aurobindo Pharma Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Dr. Reddy's Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Lupin Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sun Pharmaceutical Industries Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Divi’s Laboratories Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Aarti Drugs Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Hikal Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Neuland Labs
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Century Pharmaceuticals Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Proventus Life Sciences Pvt Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Chiral Drugs Pvt Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
USV Private Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
ASolution Pharmaceuticals Pvt. Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
11. Section
Research Methodology
About us
*Browse 28 market data tables and 34 figures on "India Active Pharmaceutical Ingredient Market” - forecast to 2028

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings